|
gptkbp:instanceOf
|
gptkb:synthetic_steroid
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:Asia
gptkb:Europe
gptkb:Latin_America
|
|
gptkbp:ATCCode
|
G03CX01
|
|
gptkbp:bioavailability
|
well absorbed
|
|
gptkbp:brand
|
Livial
|
|
gptkbp:CASNumber
|
5630-53-5
|
|
gptkbp:chemicalClass
|
19-nortestosterone derivative
|
|
gptkbp:compatibleWith
|
gptkb:United_States
|
|
gptkbp:contraindication
|
gptkb:cancer
gptkb:liver_disease
undiagnosed vaginal bleeding
|
|
gptkbp:discoveredBy
|
gptkb:Organon
|
|
gptkbp:eliminationHalfLife
|
45 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:hasMolecularFormula
|
C21H28O2
|
|
gptkbp:introducedIn
|
1988
|
|
gptkbp:KEGGID
|
D08667
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
progestogenic activity
estrogenic activity
androgenic activity
|
|
gptkbp:MeSH_ID
|
D018895
|
|
gptkbp:metabolism
|
3α-hydroxytibolone
3β-hydroxytibolone
Δ4-isomer
|
|
gptkbp:pregnancyCategory
|
X
contraindicated in pregnancy
not for use in breastfeeding
|
|
gptkbp:proteinBinding
|
high
|
|
gptkbp:PubChem_CID
|
5486
DB09073
5285
CHEMBL1200987
|
|
gptkbp:riskFactor
|
may increase risk of breast cancer recurrence
may increase risk of stroke in older women
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
abdominal pain
weight gain
breast pain
vaginal bleeding
|
|
gptkbp:synonym
|
Org OD 14
|
|
gptkbp:UNII
|
P8W5286X7A
|
|
gptkbp:usedFor
|
menopausal symptoms
prevention of osteoporosis
|
|
gptkbp:bfsParent
|
gptkb:TBZ
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tibolone
|